U.S. reclassification could drive fresh research funding into Cannabis sector Image Cannabis News May 14, 2024 Potential Rescheduling of Cannabis Sparks Optimism for Medical Research Funding. The U.S. pot sector could see an influx of medical research funding from healthcare investors amid renewed interest from pharmaceutical firms, should a proposal to reclassify cannabis as a lower-risk substance be Cannabis Technology News Marijuana Business News The Globe and Mail